Discover B2B companies, suppliers, and manufacturers related to this keyword category
We are a global allergy solutions company, pioneering in allergy research for more than 100 years.
Innovation in Immunotherapy to Treat Inflammation and Infection
BC Cancer provides a province wide, population-based cancer control program. Privacy & moderation: phsa.ca/privacy
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases.
Pioneering RNA cell therapy for autoimmune disease
Developing Innovative Cell Therapies Against Cancer
Media specialists providing cell culture solutions for industrial, clinical and research applications for over 50 years.
Leader in Genetic Testing Services, Genomics Research and Drug Discovery Solutions
The cell and gene therapy development and manufacturing organization within New York Blood Center Enterprises
Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy research.
This page is no longer active. Please follow us at Emmes. Our new website is https://www.emmes.com/emmes-europe.
Dedicated to science - Committed to your health
The leading Spatial Biology Software Platform for Precision Medicine.
The First Cell-Centered Computational Model of Human Disease
The nation's first not-for-profit biomedical research organization
Innovative pharmaceutical company revolutionizing bladder cancer treatment
Our passion drives us to provide new health solutions advancing human life
We are a San Francisco-based Venture Studio reimagining drug discovery to develop transformative immunotherapies
Enabling precision medicine to improve life for people with allergies
An Australian-first bench-to-bedside medical research institute, translating medical discoveries into improved health.
Providing high purity reagents and improved peptide binding services to drive your next HLA discovery.
Swedish biotech company exploring reprogramming as the next leap forward in cancer immunotherapy
A novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line (PDC*line)
Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer
Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges.
We are developing advanced therapies for cancer patients with critical unmet needs
Immunotherapy Ventures
Expertise in Cell and Gene Therapies, based out of Montreal QC and Toronto ON.
Permanent Self-Vaccination Against Cancer
Open cells to new possibilities: Accelerating cell therapy processes from discovery through manufacturing with Flowfect®
We support drug discovery through translational research across oncology and immuno-oncology.
Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates.
Transforming imaging data into actionable predictions
Invectys a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancers
Harnessing more of the immune system for better cancer outcomes
The science driven BioPark at the heart of Europe.
Harnessing the power of a semi-synthetic organism with an expanded genetic alphabet to develop protein therapeutics
MAIA Biotechnology is a targeted therapy, immuno-oncology company focused on development of first-in-class drugs
Bringing Effective New Treatments And Options To Patients Who Need Them
Presenting live and digital music events that raise awareness and funding for cancer treatment, research, and programs.
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation
#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation
We are the largest and best-equipped cancer treatment centre in West Africa. Radiotherapy | Brachytherapy | Chemotherapy
Davidoff center, Beilinson hospital
Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers
A biotech company developing novel dermaceutical products for oncology patients undergoing clinical treatment
Destroying tumors by targeting cancer cell fitness.
We combine multi-omics data, AI, computational biology, and MIDD for the next era of diagnosis and patient treatment.
Targeted delivery of nanoparticles for in vivo CAR T therapy
People affected by prostate cancer need breakthroughs. Research is the only way we can turn this hope to reality.
Reshaping the future of immunotherapies
From molecule to marketplace, accelerating biotech growth and gene therapies—one smart solution at a time.
Unravelling immune system function, one cell at a time
LRCG researches genetic abnormalities in acute leukaemia, assessing their diagnostic and prognostic value in trials.
is developing disruptive therapies to address critical unmet medical needs in cancer and infectious diseases.
A unique full-service CDMO, setting new standards in Cell & Gene Therapy
Eliminating the obstacles in your path to optimal wellness.
Transforming medicine through engineered cellular therapies that restore, regenerate, and repair tissues and organs.
Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science
A clinical stage biotechnology company whose mission is to create safer and more efficacious cancer therapies.
A fully integrated biotech company at the forefront of pioneering cutting-edge immunotherapies.
Achieving a better cure for cancer by cellular immunotherapy
Cutting-edge peer-reviewed research and analysis on genome editing and CRISPR biology.
Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives.
Sharing knowledge. Sharing hope.
Developing allogeneic TCR-NK therapies for solid tumors
Engineering the next-generation of T cell receptor therapies against cancer
Viral-vector therapeutics engineered for genetic stability, immunogenicity, payload capacity, & scalable manufacturing.
Telesis Bio empowers researchers with the tools to rapidly and securely design, code, and create synthetic DNA and mRNA.
Consortium dedicated to partnership-based research on lymphomas
An integrated cell therapy Contract Testing, Development and Manufacturing Organization (CTDMO)
DISCOVERING AND DEVELOPING NEW IMMUNOTHERAPY AGENTS TO IMPROVE THE LIVES OF THOSE LIVING WITH CANCER.